Oppenheimer Inc. (OPY)
NYSE: OPY
· Real-Time Price · USD
76.68
0.26 (0.34%)
At close: Sep 25, 2025, 3:59 PM
76.56
-0.16%
After-hours: Sep 25, 2025, 05:06 PM EDT
0.34% (1D)
| Bid | 73 |
| Market Cap | 799.07M |
| Revenue (ttm) | 1.49B |
| Net Income (ttm) | 87.57M |
| EPS (ttm) | 7.71 |
| PE Ratio (ttm) | 9.95 |
| Forward PE | 92.65 |
| Analyst | n/a |
| Dividends | $0.72 |
| Ask | 79 |
| Volume | 30,706 |
| Avg. Volume (20D) | 57,386.3 |
| Open | 76.30 |
| Previous Close | 76.42 |
| Day's Range | 75.75 - 77.14 |
| 52-Week Range | 47.39 - 79.99 |
| Beta | 1.19 |
| Ex-Dividend Date | Aug 15, 2025 |
5 months ago
+0.9%
Shares of financial companies are trading higher a...
Unlock content with
Pro Subscription
5 months ago
+1.78%
Shares of financial companies are trading higher amid Treasury Secretary Scott Bessent's remarks about trade de-escalation with China, which may help restore investor confidence towards the sector.
1 month ago · https://thefly.com
Y-mAbs Therapeutics downgraded to Perform from Outperform at OppenheimerOppenheimer analyst Jeff Jones downgraded Y-mAbs Therapeutics without a price target to Perform from Outperform after the company agreed to be acquired by SERB Pharmaceuticals for $8.60 per share in c...
